APOBEC3 genes: retroviral restriction factors to cancer drivers

Stephen Henderson1, Tim Fenton2

  • 1Bill Lyons Informatics Centre, University College London Cancer Institute, London, UK.

Insights

APOBEC3 enzymes are crucial for innate immunity but can also cause harmful DNA mutations during cancer development. Understanding their misdirected activity is key to cancer prevention and treatment.

Area of Science:

  • Biochemistry
  • Genetics
  • Immunology

Background:

  • APOBEC3 enzymes are critical for innate immunity, functioning as DNA deaminases that restrict viral replication.
  • Recent cancer genomics and biochemical studies implicate APOBEC3 enzymes in somatic mutagenesis during tumor development.

Purpose of the Study:

  • To review the evidence linking APOBEC3 enzymes to carcinogenesis.
  • To highlight key questions regarding APOBEC3's role in cancer, including misdirected activity, viral links, and genetic polymorphisms.

Main Methods:

  • Review of existing literature on APOBEC3 enzymes, cancer genomics, and biochemical characterization.
  • Analysis of evidence connecting APOBEC3s to somatic mutagenesis and tumor development.

Main Results:

  • At least two APOBEC3 family members are implicated in somatic mutagenesis in tumors.
  • Evidence suggests APOBEC3 activity can be misdirected to the host genome, contributing to carcinogenesis.

Conclusions:

  • APOBEC3 enzymes represent a double-edged sword in cancer, essential for immunity but potentially oncogenic.
  • Further research is needed to elucidate mechanisms of misdirected APOBEC3 activity and its link to cancer risk and viral infections.

Related Concept Videos

Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
7.3K
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

3.2K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.7K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

6.1K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
12.2K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

6.5K